Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative (18)F-FDG PET/CT analysis

BACKGROUND: Metastatic melanoma patients can have durable responses to systemic therapy and even long-term survival. However, a large subgroup of patients does not benefit. Tumour metabolic alterations may well be involved in the efficacy of both targeted and immunotherapy. Knowledge on in vivo tumo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EJNMMI Res
Main Authors: de Heer, Ellen C., Brouwers, Adrienne H., Boellaard, Ronald, Sluiter, Wim J., Diercks, Gilles F. H., Hospers, Geke A. P., de Vries, Elisabeth G. E., Jalving, Mathilde
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6246760/
https://ncbi.nlm.nih.gov/pubmed/30460579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-018-0453-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados